Plasvacc is an Australian pharmaceutical company founded in 1996. Plasvacc manufactures and distributes high quality hyperimmunised blood plasma products used to supplement the immune response system in animals. Plasma therapy shortens the course of treatments, reduces hospitalisation periods and lessens the quantity of drugs required to treat a variety of medical conditions. We are the only commercial producer of plasma for veterinary use in Australia and our facility, located in South East Queensland, is the only dedicated animal plasma production facility in the country. All Plasvacc products are registered with both the Australian Pesticide and Veterinary Medicines Authority (APVMA) and the New Zealand Food Safety Authority (NZFSA). Plasvacc is also registered with the APVMA as an approved plasma manufacturer. The techniques developed by Plasvacc to manufacture high quality plasma products have been recognised globally, with products currently supplied to over 400 clients in Australia and overseas. It is Plasvacc's rapid growth, innovative approach and commitment to quality which distinguishes the company's products in the marketplace.